Future studies focused on in vitro and in vivo models of breast cancers are needed to highlight the role of the GPR81/IGFBP6 axis in additional cell lines, homocellular the heterocellular communication, and metabolic signaling of the tumor microenvironment. This evidence concerns the gene HCAR1 and neoplasm.